Literature DB >> 3827594

Studies on the decomposition of the oxime HI 6 in aqueous solution.

P Eyer, W Hell, A Kawan, H Klehr.   

Abstract

HI 6 has been shown to be efficacious in soman intoxication of laboratory animals by reactivation of acetylcholinesterase. To assess possible risks involved in the administration of HI 6 its degradation products were analyzed at pH 2.0, 4.0, 7.4, and 9.0. At pH 2.0, where HI 6 in aqueous solution has its maximal stability, attack on the aminal-acetal bond of the "ether bridge" predominates, with formation of formaldehyde, isonicotinamide, and pyridine-2-aldoxime. Besides, HI 6 decomposes at the oxime group yielding 2-cyanopyridine. Liberation of hydrocyanic acid at pH 2.0 is below 5%. At pH 7.4, primary attack is on the oxime group, resulting in formation of the corresponding pyridone via an intermediate nitrile. The pyridone has been isolated and identified as 2-pyridinone, 1-[(4-carbamoylpyridinio)methoxy)methyl)formate. This major metabolite deaminates further to the 2-pyridinone, 1-[(4-carboxypyridinio)methoxy)methyl) derivative, which ultimately decomposes into formaldehyde, isonicotinic acid, and 2-pyridone. Hydrolysis of the acid amide group probably also occurs with HI 6 itself. Significant amounts of free hydrocyanic acid were only detected in the presence of an alkali trap; otherwise hydrocyanic acid reacts with formaldehyde to yield hydroxyacetonitrile from which hydrocyanic acid can be liberated again. Up to 0.6 equivalents of hydrocyanic acid were evolved at pH 7.4. After repetitive administration and impaired renal elimination of HI 6, e.g. during renal shock, there might be some risk of cyanide intoxication.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3827594     DOI: 10.1007/bf00290549

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  Stability of pyridine-2-aldoxime methiodide. II. Kinetics of deterioration in dilute aqueous solutions.

Authors:  R I ELLIN; J S CARLESE; A A KONDRITZER
Journal:  J Pharm Sci       Date:  1962-02       Impact factor: 3.534

2.  The nature of the toxicity of 2-oxo-oximes.

Authors:  B M ASKEW; D R DAVIES; A L GREEN; R HOLMES
Journal:  Br J Pharmacol Chemother       Date:  1956-12

3.  Hydrolysis of bis(4-hydroxyiminomethyl-1-pyridiniomethyl)ether dichloride (Toxogonin). II. Kinetics and equilibrium in acidic solution.

Authors:  I Christenson
Journal:  Acta Pharm Suec       Date:  1968-09

4.  The pharmacokinetics of HI-6 in beagle dogs.

Authors:  K J Simons; C J Briggs
Journal:  Biopharm Drug Dispos       Date:  1983 Oct-Dec       Impact factor: 1.627

5.  Cholinesterase and carboxylesterase activities in soman poisoned rats treated with bispyridinium mono-oximes HI-6 and HS-6.

Authors:  S H Sterri; S Lyngaas; F Fonnum
Journal:  Biochem Pharmacol       Date:  1983-05-15       Impact factor: 5.858

6.  HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.

Authors:  J G Clement
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

7.  Hydrolysis of obidoxime chloride (Toxogonin). 3. Kinetics in neutral and alkaline solution.

Authors:  I Christenson
Journal:  Acta Pharm Suec       Date:  1972-09

8.  HI-6 in man: blood levels, urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers.

Authors:  R Kusić; B Bosković; V Vojvodić; D Jovanović
Journal:  Fundam Appl Toxicol       Date:  1985-12

9.  Effect of HI-6, applied into the cerebral ventricles, on the inhibition of brain acetylcholinesterase by soman in rats.

Authors:  D Sket; M Brzin
Journal:  Neuropharmacology       Date:  1986-01       Impact factor: 5.250

10.  The treatment of Soman poisoning and its perspectives.

Authors:  B Bosković
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr
View more
  7 in total

1.  Study on the stability of the oxime HI 6 in aqueous solution.

Authors:  P Eyer; I Hagedorn; B Ladstetter
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

2.  Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.

Authors:  U Spöhrer; H Thiermann; R Klimmek; P Eyer
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  Operational evaluation of three commercial configurations of atropine/HI-6 wet/dry autoinjectors.

Authors:  J W Schlager; T W Dolzine; J R Stewart; G L Wannarka; M L Shih
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

4.  Formation of cyanide after i.v. administration of the oxime HI 6 to dogs.

Authors:  P Eyer; A Kawan; B Ladstetter
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

5.  HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.

Authors:  P Eyer; I Hagedorn; R Klimmek; P Lippstreu; M Löffler; H Oldiges; U Spöhrer; I Steidl; L Szinicz; F Worek
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

6.  Interaction of obidoxime with sarin in aqueous solution.

Authors:  P G Waser; C M Alioth-Streichenberg; W H Hopff; R Portmann; W Hofmann; A Niederhauser
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

7.  Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.

Authors:  P Eyer; B Ladstetter; W Schäfer; J Sonnenbichler
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.